| AAB | Acetic acid bacteria |
| ADH | Alcohol dehydrogenase |
| ALDH | Aldehyde dehydrogenase |
| ATP | Adenosine triphosphate |
| CAD | Cadaverine |
| Caco-2 | Human epithelial colorectal adenocarcinoma cell line |
| CCD-18Co | Normal human colon myofibroblast cell line |
| CFU/g | Colony-forming units per gram |
| CI | Confidence interval |
| DHAP | 2,6-Dihydroxyacetophenone |
| DPP-IV | Dipeptidyl peptidase-IV |
| ED pathway | Entner–Doudoroff pathway |
| EFeLM | Extract of fermented leaf mustard |
| EFrLM | Extract of fresh leaf mustard |
| EMP pathway | Embden–Meyerhof–Parnas pathway |
| FDA | U.S. Food and Drug Administration |
| G2/M | Gap 2/Mitosis phase (cell cycle) |
| G6PD | Glucose-6-phosphate dehydrogenase |
| GC-MS | Gas chromatography–mass spectrometry |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 | Glucagon-like peptide-1 |
| GRAS | Generally Recognized as Safe |
| HBA | 4-Hydroxybenzaldehyde |
| HCT116 | Human colon cancer cell line |
| HIS | Histamine |
| HR | Hazard ratio |
| 4-HPEA | 4-Hydroxyphenylethanol |
| IBD | Inflammatory Bowel Disease |
| IBS | Irritable bowel syndrome |
| IC50 | Half-maximal inhibitory concentration |
| LAB | Lactic acid bacteria |
| LC-MS | Liquid chromatography–mass spectrometry |
| LDH | Lactate dehydrogenase |
| NAD+ | Nicotinamide adenine dinucleotide (oxidized form) |
| NADH | Nicotinamide adenine dinucleotide (reduced form) |
| n | Sample size |
| OR | Odds ratio |
| p | Probability value (statistical significance) |
| PDC | Pyruvate decarboxylase |
| pH | Potential of Hydrogen (measure of acidity/alkalinity) |
| PUT | Putrescine |
| SMF | Submerged fermentation |
| SSF | Solid-state fermentation |
| TCA cycle | Tricarboxylic acid cycle (Krebs cycle) |
| TYR | Tyramine |
| UV | Ultraviolet (light) |
| VOCs | Volatile organic compounds |